Selected articles
Articles for label Korunková Hana are displayed.. Show all articles
Rechallenge of EGFR inhibitors in the treatment of metastatic colorectal cancer - case report
01/2020 MUDr. Hana Korunková
A case of a patient who has been treated for metastatic colorectal cancer for six years will be presented. Patient was treated with six lines of systemic treatment and two local liver treatments. All available cytostatics indicated for the diagnosis except for capecitabine, targeted therapies except bevacizumab were used in systemic treatment, and the rechallenge of the EGFR inhibitor was used.
ENTIRE ARTICLE
A case of a patient who has been treated for metastatic colorectal cancer for six years will be presented. Patient was treated with six lines of systemic treatment and two local liver treatments. All available cytostatics indicated for the diagnosis except for capecitabine, targeted therapies except bevacizumab were used in systemic treatment, and the rechallenge of the EGFR inhibitor was used.